Filtros de búsqueda

Lista de obras de Pablo Tebas

A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102

article

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

artículo científico publicado en 2016

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

artículo científico publicado en 2000

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

artículo científico publicado en 2020

A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).

artículo científico publicado en 2002

A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy

artículo científico publicado en 2014

A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults

artículo científico publicado en 2011

Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

artículo científico publicado en 2011

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

artículo científico publicado en 2000

Aging and HIV infection: a comparison between older HIV-infected persons and the general population

artículo científico publicado en 2010

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

artículo científico publicado en 2007

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection

artículo científico publicado en 2005

Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells

artículo científico publicado en 2009

Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals

artículo científico publicado en 2010

Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV

artículo científico publicado en 2012

Association Between Porphyria Cutanea Tarda and Human Immunodeficiency Virus Infection

Association between porphyria cutanea tarda and human immunodeficiency virus infection

artículo científico publicado en 1992

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy

artículo científico publicado en 2006

Bone disease and HIV infection

artículo científico publicado en 2005

Bone disease in HIV infection: a practical review and recommendations for HIV care providers

artículo científico publicado en 2010

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

artículo científico publicado en 2011

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results

artículo científico publicado en 2016

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

artículo científico publicado en 2016

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

artículo científico publicado en 2018

Cardiovascular risks of antiretroviral therapies

artículo científico publicado en 2007

Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study

artículo científico publicado en 2013

Cure of acute hepatitis C in HIV co-infection?

artículo científico publicado en 2004

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

artículo científico publicado en 2006

Current use of statins reduces risk of HIV rebound on suppressive HAART

artículo científico publicado en 2017

Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138

article

DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations

artículo científico publicado en 2007

Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19

scientific article published in 2021

Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy

artículo científico publicado en 2011

Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 Disease

article

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication

artículo científico publicado en 2000

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis

artículo científico publicado en 2013

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

artículo científico publicado en 2016

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies

artículo científico publicado en 2002

Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death

artículo científico publicado en 2013

Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

artículo científico publicado en 2015

Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384

article

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

scientific article published on 26 February 2016

Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.

artículo científico publicado en 2004

Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients

artículo científico publicado en 2011

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

artículo científico publicado en 2001

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials ⬇️

artículo científico publicado el 24 de abril de 2012

Emerging bone problems in patients infected with human immunodeficiency virus

artículo científico publicado en 2003

Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function

artículo científico publicado en 2008

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142

artículo científico publicado en 2011

Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection

artículo científico publicado en 2004

Explaining, Predicting, and Treating HIV-Associated CD4 Cell Loss

artículo científico publicado en 2006

Fat redistribution and bone abnormalities in HIV-infected patients

artículo científico publicado en 2003

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

artículo científico publicado en 2014

Genetic analysis implicates resistin in HIV lipodystrophy

artículo científico publicado en 2008

Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection

artículo científico publicado en 2003

Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks

artículo científico publicado en 2015

HIV and Cardiometabolic Abnormalities: New Perspectives and Treatment Update

article

HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells

artículo científico publicado en 2011

HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.

artículo científico publicado en 2003

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy

artículo científico publicado en 2008

Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients

artículo científico publicado en 2013

Hepatitis C virus treatment: The beginning of a new era

Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction

artículo científico publicado en 1995

High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART

artículo científico publicado en 2014

Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism

artículo científico publicado en 2008

Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease

artículo científico publicado en 2009

IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation

artículo científico publicado en 2017

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

artículo científico publicado en 2017

Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions

artículo científico publicado en 2011

Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen

artículo científico publicado en 2013

In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study

artículo científico publicado en 2013

Increased fracture risk with HIV infection--a growing concern

artículo científico publicado en 2013

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

artículo científico publicado en 2001

Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options

artículo científico publicado en 2008

Interventions for body habitus changes associated with HIV infection and its treatment

artículo científico publicado en 2007

Is it time to rethink the expanded-access programs for HIV infection?

artículo científico publicado en 2007

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

artículo científico publicado en 2015

Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials

artículo científico publicado en 2014

Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir or Efavirenz or Both Plus Dual Nucleosides

article

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

artículo científico publicado en 2003

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation

artículo científico publicado en 2013

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

artículo científico publicado en 1998

Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus

artículo científico publicado en 2003

Massively parallel pyrosequencing in HIV research

artículo científico publicado en 2008

Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease

artículo científico publicado en 2015

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

artículo científico publicado en 2008

Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks

artículo científico publicado en 2012

Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals

artículo científico publicado en 2012

Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial

artículo científico publicado en 2006

Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant

artículo científico publicado en 2014

NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects

artículo científico publicado en 2019

Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro

artículo científico publicado en 2007

Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy

artículo científico publicado en 2004

Non-tropical pyomyositis caused by Salmonella enterica enterica in an immunocompetent patient

artículo científico publicado en 1992

Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons

artículo científico publicado en 2015

Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care

artículo científico publicado en 2002

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

artículo científico publicado en 2012

Patient monitoring and follow-up in lentiviral clinical trials

artículo científico publicado en 2013

Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration

artículo científico publicado en 2012

Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s

artículo científico publicado en 2011

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.

artículo científico publicado en 2009

Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200

artículo científico publicado en 2010

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

article

Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".

artículo científico publicado en 2005

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

artículo científico publicado en 2010

Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients

artículo científico publicado en 2007

Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults

artículo científico publicado en 2007

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

artículo científico publicado en 2001

Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection

artículo científico publicado en 2014

Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient

artículo científico publicado en 1995

Real-Time Nucleic Acid Sequence-Based Amplification Assay to Quantify Changes in Mitochondrial DNA Concentrations in Cell Cultures and Blood Cells from HIV-Infected Patients Receiving Antiviral Therapy

article

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

artículo científico publicado en 2015

Reply to Rojo and Ramos and to Vignolo et al

artículo científico publicado en 2006

Response to ‘Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy’ by Drs Weil and Lenhard

article

Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic

artículo científico publicado en 2011

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection

artículo científico publicado en 2012

Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells

artículo científico publicado en 2014

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res

artículo científico publicado en 2014

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants

artículo científico publicado en 2014

Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women

artículo científico publicado en 2015

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection

artículo científico publicado en 2008

Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients

artículo científico publicado en 2015

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).

artículo científico publicado en 2007

Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals

artículo científico publicado en 2014

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

artículo científico publicado en 2002

The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.

artículo científico publicado en 2016

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling

article

The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health

artículo científico publicado en 2014

The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection

artículo científico publicado en 2016

The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana

artículo científico publicado en 2008

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

artículo científico publicado en 2007

Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy

artículo científico publicado en 2001

Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers

scientific article published on 04 June 2013

Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.

artículo científico publicado en 2017

Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model

artículo científico publicado en 1998

Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir

article

Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals

artículo científico publicado en 2012

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial

artículo científico publicado en 2015

Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection

artículo científico publicado en 2011

Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density

scientific article published on August 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda